Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Infliximab is a monoclonal antibody that targets tumor necrosis factor-α (TNFα). It is used in the treatment of a...
Enregistré dans:
Auteurs principaux: | Jennifer S Gall, Robert E Kalb |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/36deadb9adb34b80ae04e18b50667003 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ustekinumab in the therapy of chronic plaque psoriasis
par: Jenna L O’Neill, et autres
Publié: (2009) -
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
par: Santo Raffaele Mercuri, et autres
Publié: (2010) -
Infliximab in the treatment of rheumatoid arthritis
par: A Perdriger
Publié: (2009) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
par: Matsumoto S, et autres
Publié: (2018) -
Infliximab in ulcerative colitis
par: Avi Levin, et autres
Publié: (2008)